Werewolf Therapeutics Revenue and Competitors

Boston, MA USA

Location

$128.2M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Werewolf Therapeutics's estimated annual revenue is currently $7.6M per year.(i)
  • Werewolf Therapeutics's estimated revenue per employee is $168,778
  • Werewolf Therapeutics's total funding is $128.2M.
  • Werewolf Therapeutics's current valuation is $246M. (January 2022)

Employee Data

  • Werewolf Therapeutics has 45 Employees.(i)
  • Werewolf Therapeutics grew their employee count by -6% last year.

Werewolf Therapeutics's People

NameTitleEmail/Phone
1
VP, Clinical Development OperationsReveal Email/Phone
2
VP Immunology (Immuno-Oncology)Reveal Email/Phone
3
Head Clinical Pharmacology and PharmacometricsReveal Email/Phone
4
VP Program and Portfolio ManagementReveal Email/Phone
5
SVP ResearchReveal Email/Phone
6
VP Translational PharmacologyReveal Email/Phone
7
VP, LegalReveal Email/Phone
8
Chief Technology OfficerReveal Email/Phone
9
Senior Director, Clinical OperationsReveal Email/Phone
10
Senior Director, Financial Planning and AnalysisReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Werewolf Therapeutics?

We are an immuno-oncology company advancing a pipeline of next generation, transformative cancer treatments.

keywords:N/A

$128.2M

Total Funding

45

Number of Employees

$7.6M

Revenue (est)

-6%

Employee Growth %

$246M

Valuation

N/A

Accelerator

Werewolf Therapeutics News

2022-04-17 - Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Given Average ...

Werewolf Therapeutics, Inc, a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the...

2022-04-06 - Jazz Pharmaceuticals and Werewolf Therapeutics Announce ...

Werewolf Therapeutics, Inc. is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the...

2022-04-06 - Werewolf Therapeutics Shares Reverse Course Day After Deal With Jazz Pharmaceuticals

Werewolf Therapeutics Inc. shares fell roughly 19% to $4.71, erasing gains made Thursday after the company said it signed a licensing...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$27M45-62%$281.5M
#2
$3.5M4518%N/A
#3
$12.7M45-18%N/A
#4
$3.7M4518%N/A
#5
$9M45-13%N/A